Examples of 'secondary efficacy' in a sentence
Meaning of "secondary efficacy"
Secondary efficacy refers to the effectiveness of a product or treatment in achieving desired outcomes or benefits, other than the primary purpose or main effect for which it is intended. This term is often used in medical or scientific contexts when evaluating the additional positive effects of a drug or therapy beyond its primary intended use
How to use "secondary efficacy" in a sentence
Basic
Advanced
secondary efficacy
A secondary efficacy endpoint is median overall survival.
The treatment effect of icatibant was confirmed by secondary efficacy endpoints.
Evidence for secondary efficacy outcomes were of low quality.
The number of oocytes retrieved was a key secondary efficacy endpoint.
An analysis of secondary efficacy data was conducted.
Researchers also evaluated effects of the treatment on brain atrophy as a secondary efficacy measure.
The secondary efficacy variable was serum insulin concentration.
The study therefore met its primary and secondary efficacy endpoints.
This formed a secondary efficacy endpoint of the study.
Normalization of ALT was also examined as a secondary efficacy variable.
Main secondary efficacy parameters.
Efficacy Evaluations were performed using primary and secondary efficacy parameters.
Key secondary efficacy endpoints.
The CIBIC-Plus was a secondary efficacy measure.
Secondary efficacy endpoints were compared across all treatment groups.
See also
The analysis for all primary and secondary efficacy endpoints occurs at one year.
Secondary efficacy outcomes were generally consistent with the primary outcome.
Live birth rate was a secondary efficacy endpoint in ENGAGE and PURSUE.
Secondary efficacy objective.
Results of primary and secondary efficacy measures-ITT population.
The secondary efficacy endpoints included the investigators evaluation of improvement.
Additional clinically-relevant parameters were evaluated as secondary efficacy assessments.
The secondary efficacy endpoints were supportive of the primary efficacy endpoints.
Furthermore, there was no clinical benefit in key secondary efficacy endpoints.
Secondary efficacy outcome measures included overall response rate and overall survival.
A tabular summary of the secondary efficacy results is presented in Table 3.
Secondary efficacy outcome measures were ORR and response duration.
A tabular summary of these secondary efficacy results is presented in Table 4.
The secondary efficacy endpoint of the study is the progression of the cerebral disease.
This endpoint was defined as the key secondary efficacy endpoint for Study 1.
Several secondary efficacy measures were analyzed to confirm the findings of the primary measure.
Results of comparisons of the primary and secondary efficacy variables are summarised in Table 1.
The secondary efficacy endpoints will be analysed following the statistical procedures presented below.
PFS assessed by blinded independent radiology review ( BIR ) was a key secondary efficacy outcome.
None of the secondary efficacy variables for clonidine treatment groups were significantly different from placebo.
The same 2-way ANCOVA model will be used for the analysis of secondary efficacy variables.
Secondary efficacy endpoints were established for IVUS and angiography.
The analyses of other pre-specified secondary efficacy endpoints in BENEFIT-ALS produced mixed results.
Secondary efficacy endpoints included OS and ORR.
All phase III studies used the same pre-defined primary and secondary efficacy outcomes.
Results for secondary efficacy endpoints were consistent with the results for ACD.
Decreased appetite, patient has a little increase in appetite . Secondary Efficacy Evaluations.
The secondary efficacy variable was FPG.
Table 1, Results of primary and selected secondary efficacy assessments in Phase III studies.
Secondary efficacy parameters included the following,.
Table 2, Results of primary and selected secondary efficacy assessments in long term Phase III studies.
A secondary efficacy variable was change in visual acuity at week 24 compared to baseline.
Confidence interval non-inferiority margin Secondary efficacy endpoints Recurrent symptomatic VTE and allcause deaths.
Secondary efficacy endpoints included progression-free survival and objective response rate.
Einstein DVT, PE and Extension used the same pre-defined primary and secondary efficacy outcomes.
You'll also be interested in:
Examples of using Efficacy
Show more
The efficacy of alternatives would need to be considered
Improved prediction of efficacy early indication of efficacy
Efficacy and efficiency of possible control measures
Examples of using Secondary
Show more
No secondary cases were found following this importation
Associated and secondary data centre costs
Secondary information published in the form of reports
